TherapeuticsMD, Inc. (TXMD)

5d ago, source: Yahoo Finance

BOCA RATON, Fla., March 29, 2024--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results ...

TherapeuticsMD Announces Full Year 2023 Financial Results

27d ago, source: Yahoo Finance

BOCA RATON, Fla., March 29, 2024--(BUSINESS WIRE)--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to ...

TherapeuticsMD gets grant for progesterone formulation for oral administration with reduced dosage

6d ago, source: Pharmaceutical Technology

Discover TherapeuticsMD Inc's innovative patent for progesterone formulations, offering reduced dosage with maintained efficacy. Learn about the groundbreaking pharmaceutical composition designed for ...

TherapeuticsMD, Inc. (TXMD) stock price, news, quote & history – Yahoo Finance

1y ago, source: Yahoo Finance

BOCA RATON, Fla., November 14, 2023--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results ...

TherapeuticsMD (TXMD) Earnings Dates & Reports

27d ago, source: Investing

View upcoming earnings forecasts and in-depth analysis of company forecasts.

TherapeuticsMD Inc TXMD

9d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

TherapeuticsMD Announces Full Year 2023 Financial Results

26d ago, source: Stockhouse

TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial ...

TherapeuticsMD Inc

1y ago, source: OpenSecrets.org

NOTE: All lobbying expenditures on this page come from the Senate Office of Public Records. Data for the most recent year was downloaded on April 24, 2018. Feel free to distribute or cite this ...

TherapeuticsMD Announces Full Year 2023 Financial Results

26d ago, source:

TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, ...